Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over. NICE technology appraisal guidance 1077
National Institute for Health and Care Excellence (NICE)
Record ID 32018014415
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta1077
Year Published:
2025
URL for published report:
https://www.nice.org.uk/guidance/ta1077
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Dermatitis, Atopic
- Antibodies, Monoclonal, Humanized
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
3rd floor, 3 Piccadilly Place, Manchester, M1 3BN
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.